Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Trop, M; Novak, M; Rodl, S; Hellbom, B; Kroell, W; Goessler, W.
Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient.
J TRAUMA. 2006; 60(3): 648-652. Doi: 10.1097/01.ta.0000208126.22089.b6 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Trop Marija
Co-Autor*innen der Med Uni Graz
Hellbom Bengt
Kröll Wolfgang
Roedl Siegfried
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Treatment of acute burn wounds with silver sulfadiazine (SSD) has raised concern about potential silver toxicity. Numerous adverse reactions and side effects have been reported and an increasing resistance to SSD, especially in Pseudomonas strains, have motivated researchers to search for an alternative wound dressing. METHODS: Recently, a silver-coated wound dressing Acticoat (Smith & Nephew, Inc.) has become available for use in burn patients. It is a three-ply dressing, consisting of an inner rayon/polyester absorptive core between two layers of silver-coated, high-density polyethylene mesh. In a moist environment, the nanocrystals of silver are released and improve the microbial control in the wound. RESULTS: After 1 week of local treatment with Acticoat in a young, previously healthy 17-year-old boy with 30% mixed depth burns, hepatotoxicity and argyria-like symptoms, a grayish discoloration of the patient's face, appeared. The silver levels in plasma (107 microg/kg) and urine (28 microg/kg) were clearly elevated, as well as the liver enzymes. As soon as the local application of Acticoat was aborted, the clinical symptoms and liver enzymes returned to the normal values. CONCLUSIONS: This is the first report on silver toxicity in a patient with 30% burns who received Acticoat for local treatment. Due to substantial experiences with adverse SSD reactions and side effects, it is appropriate to keep the possibility of a toxic silver effect in burn patients treated with Acticoat silver-coated wound dressing in mind. The silver levels in plasma and/or urine should be monitored.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Alanine Transaminase - blood
Anti-Infective Agents, Local - toxicity
Argyria - diagnosis Argyria - etiology
Aspartate Aminotransferases - blood
Bandages -
Burns - therapy
Diagnosis, Differential -
Drug-Induced Liver Injury - diagnosis Drug-Induced Liver Injury - etiology
Humans -
Liver Function Tests -
Male -
Silver - pharmacokinetics
Silver Sulfadiazine - toxicity
gamma-Glutamyltransferase - blood

Find related publications in this database (Keywords)
burns
Acticoat
silver toxicity
© Med Uni Graz Impressum